Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.
scientific article
Author/s
author: Derralynn A Hughes, Kathy Nicholls, Gere Sunder-Plassmann, Jerry Vockley, Robin Lachmann, David Dimmock, Dominique P Germain, Éric Hachulla, Daniel-G. Bichet, Ulla Feldt-Rasmussen, Patrick B Deegan, Raphael Schiffmann
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.